4.5 Article

Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor

Journal

PARKINSONISM & RELATED DISORDERS
Volume 16, Issue 2, Pages 112-114

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2009.08.011

Keywords

Parkinson disease; Essential tremor; Histamine; HNMT

Funding

  1. Morris K. Udall Parkinson's Disease Research Center of Excellence [NS40256]
  2. Pacific Alzheimer Research Foundation (PARF) [C06-01]
  3. CIHR [121849]
  4. [P01 AG017216]
  5. [R01 NS057567]
  6. [R01 AG015866]

Ask authors/readers for more resources

A functional variant in the Histamine N-Methyltransferase gene (HNMT - rs11558538) resulting in a threonine to isoleucine substitution (Thr105Ile) has been shown to impair histamine degradation. Two recent studies reported that the threonine allele of this polymorphism might be a risk factor for Parkinson disease (PD) and essential tremor (ET) development. Although PD and ET are considered different entities, they share some clinical and pathological features, suggesting a possible joint etiology. In this study we assess the role of the Thr105Ile variant in PD and ET development, genotyping the variant in a North American Caucasian PD and ET case-control series. Statistical analysis did not identify any significant association between this Variant and PD or ET; therefore, our findings do not support the HNMT Thr105Ile variant as a factor in disease development or a genetic link between the disorders. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available